Composite Glucose and C-Peptide Endpoints Show Early Efficacy in Recent-Onset Type 1 Diabetes (T1D) Clinical Trials

被引：0
|
作者：
Jacobsen, Laura M.
Cuthbertson, David D.
Haller, Michael J.
Ismail, Heba M.
Sims, Emily K.
Gitelman, Stephen E.
Wherrett, Diane K.
Moran, Antoinette
Atkinson, Mark A.
Pugliese, Alberto
Gottlieb, Peter
Sosenko, Jay
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-825-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
825-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Heterogeneity in recent-onset type 1 diabetes - a clinical trial perspective
    Bollyky, Jennifer B.
    Xu, Ping
    Butte, Atul J.
    Wilson, Darrell M.
    Beam, Craig A.
    Greenbaum, Carla J.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (06) : 588 - 594
  • [32] Polyclonal anti-T-lymphocyte globulin preserves C-peptide production in type 1 diabetes of recent onset
    Saudek, F.
    Havrdova, T.
    Boucek, P.
    Hirsch, H. H.
    Zacharovova, K.
    Lanska, V.
    DIABETOLOGIA, 2008, 51 : S234 - S235
  • [33] A Comparison of C -Peptide and Glucose Responses between Children and Adolescents Who Progress to Type 1 Diabetes (T1D)
    Ismail, Heba M.
    Nathan, Brandon M.
    Palmer, Jerry P.
    Dimeglio, Linda
    Sosenko, Jay M.
    DIABETES, 2019, 68
  • [34] Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
    Staeva, Teodora P.
    Chatenoud, Lucienne
    Insel, Richard
    Atkinson, Mark A.
    DIABETES, 2013, 62 (01) : 9 - 17
  • [35] The 2-hr glucose and the AUC glucose-AUC C-peptide ratio as predictors of T1D in diabetes prevention trial-type 1 (DPT-1) participants
    Sosenko, JM
    Palmer, JP
    Greenbaum, CJ
    Cowie, CC
    Mahon, J
    Chase, HP
    White, NH
    Cuthbertson, DD
    Krischer, JP
    Skyler, JS
    DIABETES, 2005, 54 : A456 - A456
  • [36] C-peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277 An Exploratory Study
    Buzzetti, Raffaella
    Cernea, Simona
    Petrone, Antonio
    Capizzi, Marco
    Spoletini, Marialuisa
    Zampetti, Simona
    Guglielmi, Chiara
    Venditti, Chiara
    Pozzilli, Paolo
    DIABETES, 2011, 60 (11) : 3067 - 3072
  • [37] The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
    Wahren, John
    Kallas, Asa
    Sima, Anders A. F.
    DIABETES, 2012, 61 (04) : 761 - 772
  • [38] Effect of C-peptide on glucose metabolism in patients with type 1 diabetes
    Forst, T
    Rave, K
    Pfuetzner, A
    Buchholz, R
    Pohlmann, T
    Löbig, M
    Heinemann, L
    DIABETES CARE, 2002, 25 (06) : 1096 - 1097
  • [39] Comparisons of Combined C-Peptide and Glucose Intermediate Endpoints for Identifying Individuals at Very High Risk for Type 1 Diabetes
    Jacobsen, Laura M.
    Clements, Mark A.
    Redondo, Maria Jose
    Nathan, Brandon M.
    Schatz, Desmond
    Sosenko, Jay M.
    DIABETES, 2019, 68
  • [40] Glucose and C-peptide changes in the peri-onset period of type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1)
    Sosenko, J.
    Palmer, J.
    Raftin-Mervis, L.
    Krischer, J.
    Cuth-Bertson, D.
    Matheson, D.
    Skyler, J.
    ACTA DIABETOLOGICA, 2007, 44 : S49 - S50
12345